Biden's HHS Withdraws Rule Tying Drug Payments to Foreign Rates – Bloomberg Law

By Ian Lopez
The Biden administration on Monday withdrew a Trump-era rule tying U.S. drug payments to cheaper foreign rates amid an ongoing government push to curb rising pharmaceutical costs.
The Trump-era rule (RIN 0938-AT91) matched Medicare reimbursement for drugs administered in doctors’ offices—which are usually expensive and often for serious illnesses—to lower prices paid in other countries. The HHS, under President Joe Biden, said it was exploring other options to improve the quality and cost of care for beneficiaries.
The rule was finalized in 2020, but it was blocked by federal judges and paused by Biden.
To contact the reporter on this story: Ian Lopez in Washington at ilopez@bloomberglaw.com
To contact the editor responsible for this story: Alexis Kramer at akramer@bloomberglaw.com
To read more articles log in.
Learn more about a Bloomberg Law subscription.

source

Leave a Comment

Your email address will not be published.

Shopping Cart